NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO), a biomedical technology company pioneering high-impact therapeutic solutions, announced its participation in several key investor conferences slated for late February and March 2025. These engagements underscore the company’s commitment to fostering strong relationships with the investment community and sharing updates on its strategic initiatives.
Conference Schedule
- TD Cowen 45th Annual Healthcare Conference
- Format: Corporate Presentation
- Date: March 3, 2025
- Time: 2:30 PM ET
- A live audio webcast will be accessible through the “Investors” section of Orchestra BioMed’s website. The webcast will remain available as a replay for 90 days following the event.
- Barclays 27th Annual Global Healthcare Conference
- Format: Fireside Chat
- Date: March 13, 2025
- Time: 8:00 AM ET
Additionally, Orchestra BioMed will conduct one-on-one meetings with investors at the B. Riley Securities Precision Oncology & RadioPharma Conference on February 28, 2025.
Engagement and Accessibility
These conferences provide Orchestra BioMed an opportunity to connect directly with current and prospective investors, offering insights into the company’s innovative technologies, strategic outlook, and growth priorities. Notably, the live webcast of the TD Cowen presentation will make it easier for interested parties to virtually access the updates shared during the session.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.